Loading...
The Chest Pain Problem 2017-08-25T20:39:53+00:00

Genetesis wants to change the standard of care in emergency departments around the world to optimize cost, enhance clinical outcomes, and get patients in and out faster than ever before. To get there, we are first solving the challenges associated with chest pain triage and stratifying risk in coronary artery disease.

Chest pain triage today is an imprecise, drawn out process.

Chest pain accounts for nearly 8 million emergency room visits in the U.S. every year1 . Ultimately, about 75% of these cases will be non-cardiac origin chest pain (i.e. musculoskeletal pain). Despite this, determining whether a patient’s chest pain is cardiac is complex and inefficient. Some of the problems with the current standard of care include:

Lengthy Testing

The full triage process can last between 12 and 36 hours due to the need for serial testing and specialized technician support. Lost professional time and the sheer ineffectiveness of existing diagnostics not only uses up unnecessary hospital beds, but puts payers, hospitals, and patients at huge financial loss.

Invasive Tests

Patients are subjected to multiple blood draws throughout the triage process. Some testing can involve the use of drugs to artificially increase heart rate, the injection of radioisotopes, and considerable radiation given to patients. Despite this, these tests often lead to incorrect diagnoses.

Diminished Care

The combined inefficiency of current diagnostic tests, coupled with the loss of clinical resources from lengthy procedures decreases overall timeliness and quality of care. What’s worse, these tests often miss serious heart disease in patients who are sent home.

Our Mission is to use biomagnetic imaging– a passive tool that has zero radiation exposure, requires no injections, and emits less energy than a TV– To solve this unmet clinical need and many others and to create a new paradigm in emergency care.

Learn more about our products and solutions